US Stock MarketDetailed Quotes

TRDA Entrada Therapeutics

Watchlist
  • 12.360
  • -0.070-0.56%
Close Apr 25 16:00 ET
415.31MMarket Cap-61800P/E (TTM)

Entrada Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
129.01M
41.85M
43.74M
18.17M
25.26M
0
0
0
0
0
Operating revenue
--129.01M
--41.85M
--43.74M
--18.17M
--25.26M
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
35.92%132.18M
44.43%36.94M
14.60%29.72M
46.17%34.47M
40.13%31.04M
90.21%97.25M
38.56%25.58M
80.56%25.94M
137.96%23.58M
163.92%22.15M
Selling and administrative expenses
5.39%32.29M
-12.55%8.65M
7.94%7.53M
11.39%8.17M
23.39%7.94M
101.56%30.64M
62.25%9.89M
81.20%6.98M
138.04%7.33M
196.45%6.43M
-General and administrative expense
5.39%32.29M
-12.55%8.65M
7.94%7.53M
11.39%8.17M
23.39%7.94M
101.56%30.64M
62.25%9.89M
81.20%6.98M
138.04%7.33M
196.45%6.43M
Research and development costs
49.96%99.88M
80.37%28.29M
17.05%22.19M
61.87%26.3M
46.98%23.1M
85.41%66.61M
26.88%15.69M
80.33%18.96M
137.93%16.25M
152.58%15.72M
Operating profit
96.75%-3.16M
119.18%4.91M
154.03%14.01M
30.88%-16.3M
73.91%-5.78M
-90.21%-97.25M
-38.56%-25.58M
-80.56%-25.94M
-137.96%-23.58M
-163.92%-22.15M
Net non-operating interest income expense
478.19%15.22M
351.79%4.29M
407.01%4.05M
946.65%4.22M
453.54%2.66M
8,590.32%2.63M
7,207.69%950K
1,310.61%799K
4,377.78%403K
3,592.31%480K
Non-operating interest income
478.19%15.22M
351.79%4.29M
407.01%4.05M
946.65%4.22M
453.54%2.66M
--2.63M
--950K
--799K
4,377.78%403K
3,592.31%480K
Other net income (expense)
Income before tax
112.74%12.06M
137.34%9.2M
171.86%18.06M
47.88%-12.08M
85.59%-3.12M
-84.95%-94.62M
-33.51%-24.63M
-74.20%-25.14M
-134.11%-23.18M
-158.60%-21.67M
Income tax
18.74M
18.74M
-17.4M
13.85M
3.55M
0
0
0
0
0
Net income
92.93%-6.69M
61.25%-9.54M
241.07%35.46M
-11.86%-25.93M
69.20%-6.67M
-84.95%-94.62M
-33.51%-24.63M
-74.20%-25.14M
-134.11%-23.18M
-158.60%-21.67M
Net income continuous Operations
92.93%-6.69M
61.25%-9.54M
241.07%35.46M
-11.86%-25.93M
69.20%-6.67M
-84.95%-94.62M
-33.51%-24.63M
-74.20%-25.14M
-134.11%-23.18M
-158.60%-21.67M
Minority interest income
Net income attributable to the parent company
92.93%-6.69M
61.25%-9.54M
241.07%35.46M
-11.86%-25.93M
69.20%-6.67M
-84.95%-94.62M
-33.51%-24.63M
-74.20%-25.14M
-134.11%-23.18M
-158.60%-21.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
92.93%-6.69M
61.25%-9.54M
241.07%35.46M
-11.86%-25.93M
69.20%-6.67M
-84.95%-94.62M
-33.51%-24.63M
-74.20%-25.14M
-134.11%-23.18M
-158.60%-21.67M
Basic earnings per share
93.38%-0.2
63.29%-0.29
233.75%1.07
-5.41%-0.78
69.57%-0.21
62.99%-3.02
11.24%-0.79
-56.96%-0.8
-53.04%-0.74
-68.60%-0.69
Diluted earnings per share
93.38%-0.2
63.29%-0.29
227.50%1.02
-5.41%-0.78
69.57%-0.21
62.99%-3.02
11.24%-0.79
-56.96%-0.8
-53.04%-0.74
-68.60%-0.69
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 129.01M41.85M43.74M18.17M25.26M00000
Operating revenue --129.01M--41.85M--43.74M--18.17M--25.26M--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 35.92%132.18M44.43%36.94M14.60%29.72M46.17%34.47M40.13%31.04M90.21%97.25M38.56%25.58M80.56%25.94M137.96%23.58M163.92%22.15M
Selling and administrative expenses 5.39%32.29M-12.55%8.65M7.94%7.53M11.39%8.17M23.39%7.94M101.56%30.64M62.25%9.89M81.20%6.98M138.04%7.33M196.45%6.43M
-General and administrative expense 5.39%32.29M-12.55%8.65M7.94%7.53M11.39%8.17M23.39%7.94M101.56%30.64M62.25%9.89M81.20%6.98M138.04%7.33M196.45%6.43M
Research and development costs 49.96%99.88M80.37%28.29M17.05%22.19M61.87%26.3M46.98%23.1M85.41%66.61M26.88%15.69M80.33%18.96M137.93%16.25M152.58%15.72M
Operating profit 96.75%-3.16M119.18%4.91M154.03%14.01M30.88%-16.3M73.91%-5.78M-90.21%-97.25M-38.56%-25.58M-80.56%-25.94M-137.96%-23.58M-163.92%-22.15M
Net non-operating interest income expense 478.19%15.22M351.79%4.29M407.01%4.05M946.65%4.22M453.54%2.66M8,590.32%2.63M7,207.69%950K1,310.61%799K4,377.78%403K3,592.31%480K
Non-operating interest income 478.19%15.22M351.79%4.29M407.01%4.05M946.65%4.22M453.54%2.66M--2.63M--950K--799K4,377.78%403K3,592.31%480K
Other net income (expense)
Income before tax 112.74%12.06M137.34%9.2M171.86%18.06M47.88%-12.08M85.59%-3.12M-84.95%-94.62M-33.51%-24.63M-74.20%-25.14M-134.11%-23.18M-158.60%-21.67M
Income tax 18.74M18.74M-17.4M13.85M3.55M00000
Net income 92.93%-6.69M61.25%-9.54M241.07%35.46M-11.86%-25.93M69.20%-6.67M-84.95%-94.62M-33.51%-24.63M-74.20%-25.14M-134.11%-23.18M-158.60%-21.67M
Net income continuous Operations 92.93%-6.69M61.25%-9.54M241.07%35.46M-11.86%-25.93M69.20%-6.67M-84.95%-94.62M-33.51%-24.63M-74.20%-25.14M-134.11%-23.18M-158.60%-21.67M
Minority interest income
Net income attributable to the parent company 92.93%-6.69M61.25%-9.54M241.07%35.46M-11.86%-25.93M69.20%-6.67M-84.95%-94.62M-33.51%-24.63M-74.20%-25.14M-134.11%-23.18M-158.60%-21.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 92.93%-6.69M61.25%-9.54M241.07%35.46M-11.86%-25.93M69.20%-6.67M-84.95%-94.62M-33.51%-24.63M-74.20%-25.14M-134.11%-23.18M-158.60%-21.67M
Basic earnings per share 93.38%-0.263.29%-0.29233.75%1.07-5.41%-0.7869.57%-0.2162.99%-3.0211.24%-0.79-56.96%-0.8-53.04%-0.74-68.60%-0.69
Diluted earnings per share 93.38%-0.263.29%-0.29227.50%1.02-5.41%-0.7869.57%-0.2162.99%-3.0211.24%-0.79-56.96%-0.8-53.04%-0.74-68.60%-0.69
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg